These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 15741258)

  • 1. Antibody response to inhaled insulin in patients with type 1 or type 2 diabetes. An analysis of initial phase II and III inhaled insulin (Exubera) trials and a two-year extension trial.
    Fineberg SE; Kawabata T; Finco-Kent D; Liu C; Krasner A
    J Clin Endocrinol Metab; 2005 Jun; 90(6):3287-94. PubMed ID: 15741258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and efficacy of inhaled human insulin (Exubera) during discontinuation and readministration of therapy in adults with type 1 diabetes: A 3-year randomized controlled trial.
    Skyler JS; Hollander PA; Jovanovic L; Klioze S; Krasner A; Riese RJ; Reis J; Schwartz P; Duggan W;
    Diabetes Res Clin Pract; 2008 Nov; 82(2):238-46. PubMed ID: 18824271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary function over 2 years in diabetic patients treated with prandial inhaled Technosphere Insulin or usual antidiabetes treatment: a randomized trial.
    Raskin P; Heller S; Honka M; Chang PC; Boss AH; Richardson PC; Amin N
    Diabetes Obes Metab; 2012 Feb; 14(2):163-73. PubMed ID: 21951325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin antibodies with pulmonary delivery of insulin.
    Fineberg SE; Kawabata TT; Krasner AS; Fineberg NS
    Diabetes Technol Ther; 2007 Jun; 9 Suppl 1():S102-10. PubMed ID: 17563298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two-year safety and efficacy of inhaled human insulin (Exubera) in adult patients with type 1 diabetes.
    Skyler JS; Jovanovic L; Klioze S; Reis J; Duggan W;
    Diabetes Care; 2007 Mar; 30(3):579-85. PubMed ID: 17327324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Perspectives of inhaled insulin treatment].
    Chodorowski Z; Sein Anand J
    Przegl Lek; 2007; 64(4-5):365-7. PubMed ID: 17724916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of inhaled insulin (Exubera) compared with subcutaneous insulin therapy in patients with type 1 diabetes: results of a 6-month, randomized, comparative trial.
    Quattrin T; Bélanger A; Bohannon NJ; Schwartz SL;
    Diabetes Care; 2004 Nov; 27(11):2622-7. PubMed ID: 15504996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of long-term immunological and pulmonary safety of inhaled human insulin with up to 24 months of continuous therapy.
    Cefalu WT; Bohannon NJ; Edwin Fineberg S; Teeter JG; Schwartz PF; Reis JM; Krasner AS
    Curr Med Res Opin; 2008 Nov; 24(11):3073-83. PubMed ID: 18828959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhaled insulin: a novel and non-invasive way for insulin administration?
    Quattrin T
    Curr Drug Saf; 2006 May; 1(2):151-8. PubMed ID: 18690926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhaled human insulin ((insulin human [rDNA origin]) Inhalation Powder) in diabetes mellitus.
    Mathieu C
    Expert Opin Drug Metab Toxicol; 2006 Oct; 2(5):779-91. PubMed ID: 17014394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of inhaled human insulin (exubera) during discontinuation and readministration of therapy in adults with type 2 diabetes: a 3-year randomized controlled trial.
    Rosenstock J; Cefalu WT; Hollander PA; Klioze SS; Reis J; Duggan WT
    Diabetes Technol Ther; 2009 Nov; 11(11):697-705. PubMed ID: 19905885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized study to characterize glycemic control and short-term pulmonary function in patients with type 1 diabetes receiving inhaled human insulin (exubera).
    Norwood P; Dumas R; Cefalu W; Yale JF; England R; Riese R; Teeter J
    J Clin Endocrinol Metab; 2007 Jun; 92(6):2211-4. PubMed ID: 17003088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term tolerability of inhaled human insulin (Exubera) in patients with poorly controlled type 2 diabetes.
    Barnett AH; Lange P; Dreyer M; Serdarevic-Pehar M;
    Int J Clin Pract; 2007 Oct; 61(10):1614-25. PubMed ID: 17877648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhaled human insulin (Exubera): a review of its use in adult patients with diabetes mellitus.
    Dunn C; Curran MP
    Drugs; 2006; 66(7):1013-32. PubMed ID: 16740022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhaled insulin (exubera).
    Med Lett Drugs Ther; 2006 Jul; 48(1239):57-8. PubMed ID: 16841019
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhaled human insulin.
    Strack TR
    Drugs Today (Barc); 2006 Apr; 42(4):207-21. PubMed ID: 16703118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhaled insulin improves glycemic control when substituted for or added to oral combination therapy in type 2 diabetes: a randomized, controlled trial.
    Rosenstock J; Zinman B; Murphy LJ; Clement SC; Moore P; Bowering CK; Hendler R; Lan SP; Cefalu WT
    Ann Intern Med; 2005 Oct; 143(8):549-58. PubMed ID: 16230721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-analysis: efficacy and safety of inhaled insulin therapy in adults with diabetes mellitus.
    Ceglia L; Lau J; Pittas AG
    Ann Intern Med; 2006 Nov; 145(9):665-75. PubMed ID: 17088580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unlocking the opportunity of tight glycaemic control. Inhaled insulin: clinical efficacy.
    Scherbaum WA
    Diabetes Obes Metab; 2005 Nov; 7 Suppl 1():S9-13. PubMed ID: 16135137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhaled dry powder insulin for the treatment of diabetes mellitus.
    Setter SM; Levien TL; Iltz JL; Odegard PS; Neumiller JJ; Baker DE; Campbell RK
    Clin Ther; 2007 May; 29(5):795-813. PubMed ID: 17697900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.